IS7310A - 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar - Google Patents

3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar

Info

Publication number: IS7310A
Authority: IS; Iceland
Prior art keywords: tafia; imidazolyl; inhibit; alkoxypropanoic; acids
Prior art date: 2002-01-22

Application number

IS7310A

Other languages

English (en)

Inventor

Moira Norfor Allerton Charlotte

John Bull David

Edward Bunnage Mark

Sandwich

John Maguire Robert

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-22

Filing date

2004-06-14

Publication date

2004-06-14

2002-01-22 Priority claimed from GB0201389A external-priority patent/GB0201389D0/en

2002-01-29 Priority claimed from GB0202027A external-priority patent/GB0202027D0/en

2004-06-14 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2004-06-14 Publication of IS7310A publication Critical patent/IS7310A/is

Links

239000002253 acid Substances 0.000 title 1
150000007513 acids Chemical class 0.000 title 1
125000002883 imidazolyl group Chemical group 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IS7310A 2002-01-22 2004-06-14 3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar IS7310A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0201389A GB0201389D0 (en)	2002-01-22	2002-01-22	3-(imidazolyl)-2-alkoxypropanoic acids
GB0202027A GB0202027D0 (en)	2002-01-29	2002-01-29	3-(imidazolyl)-2-alkoxypropanoic acids
PCT/IB2003/000060 WO2003061652A1 (en)	2002-01-22	2003-01-10	3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors

Publications (1)

Publication Number	Publication Date
IS7310A true IS7310A (is)	2004-06-14

Family

ID=27614792

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7310A IS7310A (is)	2002-01-22	2004-06-14	3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar

Country Status (24)

Country	Link
EP (1)	EP1467731A1 (is)
JP (1)	JP2005520811A (is)
KR (1)	KR20040077775A (is)
CN (1)	CN1620291A (is)
AP (1)	AP2004003084A0 (is)
AR (1)	AR038197A1 (is)
BR (1)	BR0307016A (is)
CA (1)	CA2472238A1 (is)
EA (1)	EA200400716A1 (is)
EC (1)	ECSP045200A (is)
HR (1)	HRP20040659A2 (is)
IL (1)	IL162677A0 (is)
IS (1)	IS7310A (is)
MA (1)	MA27167A1 (is)
MX (1)	MXPA04006573A (is)
NO (1)	NO20043457L (is)
OA (1)	OA12756A (is)
PA (1)	PA8563501A1 (is)
PE (1)	PE20030929A1 (is)
PL (1)	PL371487A1 (is)
TN (1)	TNSN04121A1 (is)
TW (1)	TW200302094A (is)
UY (1)	UY27615A1 (is)
WO (1)	WO2003061652A1 (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005051384A1 (en) *	2003-11-25	2005-06-09	Pfizer Limited	Stabilised pharmaceutical compositions
JP2008536923A (ja) *	2005-04-18	2008-09-11	バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト	心筋の再灌流の増強およびｐｃｉの容易化のためのｔａｆｉ阻害剤の使用
CA2741783A1 (en)	2008-10-29	2010-05-06	Taisho Pharmaceutical Co., Ltd.	Compounds having tafia inhibitory activity
AU2009322342A1 (en) *	2008-12-05	2011-06-30	Merck Sharp & Dohme Corp.	Morpholinone compounds as factor IXa inhibitors
US8987242B2 (en)	2008-12-05	2015-03-24	Merck Sharp & Dohme Corp.	Morpholinone compounds as factor IXA inhibitors
CA2793523C (en) *	2010-03-18	2015-05-05	Daiichi Sankyo Company, Limited	Cyclopropanecarboxylic acid derivative
RU2572814C2 (ru)	2010-03-18	2016-01-20	Дайити Санкио Компани, Лимитед	ЦИКЛОАЛКИЛ-ЗАМЕЩЕННОЕ ПРОИЗВОДНОЕ ИМИДАЗОЛА, ОБЛАДАЮЩЕЕ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ TAFIa
WO2014198620A1 (en)	2013-06-10	2014-12-18	Sanofi	Macrocyclic urea derivatives as inhibitors of tafia, their preparation and their use as pharmaceuticals
CN108883094A (zh)	2016-03-29	2018-11-23	第三共株式会社	炎症性肠病治疗剂
MY202326A (en)	2017-09-14	2024-04-24	Daiichi Sankyo Co Ltd	Compound having cyclic structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9901572D0 (sv) *	1999-05-03	1999-05-03	Astra Ab	New compounds
WO2002014285A1 (en) *	2000-08-17	2002-02-21	Pfizer Limited	Substituted imidazoles as tafia inhibitors

2003
- 2003-01-10 WO PCT/IB2003/000060 patent/WO2003061652A1/en not_active Ceased
- 2003-01-10 PL PL03371487A patent/PL371487A1/xx unknown
- 2003-01-10 CA CA002472238A patent/CA2472238A1/en not_active Abandoned
- 2003-01-10 AP APAP/P/2004/003084A patent/AP2004003084A0/en unknown
- 2003-01-10 CN CNA03802599XA patent/CN1620291A/zh active Pending
- 2003-01-10 EP EP03700059A patent/EP1467731A1/en not_active Withdrawn
- 2003-01-10 EA EA200400716A patent/EA200400716A1/ru unknown
- 2003-01-10 HR HR20040659A patent/HRP20040659A2/hr not_active Application Discontinuation
- 2003-01-10 JP JP2003561596A patent/JP2005520811A/ja active Pending
- 2003-01-10 IL IL16267703A patent/IL162677A0/xx unknown
- 2003-01-10 BR BR0307016-6A patent/BR0307016A/pt not_active IP Right Cessation
- 2003-01-10 MX MXPA04006573A patent/MXPA04006573A/es unknown
- 2003-01-10 OA OA1200400190A patent/OA12756A/en unknown
- 2003-01-10 KR KR10-2004-7011370A patent/KR20040077775A/ko not_active Ceased
- 2003-01-16 TW TW092100889A patent/TW200302094A/zh unknown
- 2003-01-17 PE PE2003000058A patent/PE20030929A1/es not_active Application Discontinuation
- 2003-01-20 UY UY27615A patent/UY27615A1/es not_active Application Discontinuation
- 2003-01-21 AR ARP030100165A patent/AR038197A1/es unknown
- 2003-01-22 PA PA20038563501A patent/PA8563501A1/es unknown
2004
- 2004-06-14 IS IS7310A patent/IS7310A/is unknown
- 2004-06-30 TN TNP2004000121A patent/TNSN04121A1/en unknown
- 2004-07-15 MA MA27786A patent/MA27167A1/fr unknown
- 2004-07-22 EC EC2004005200A patent/ECSP045200A/es unknown
- 2004-08-19 NO NO20043457A patent/NO20043457L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
OA12756A (en)	2006-07-03
MA27167A1 (fr)	2005-01-03
IL162677A0 (en)	2005-11-20
EP1467731A1 (en)	2004-10-20
TW200302094A (en)	2003-08-01
BR0307016A (pt)	2004-11-03
CN1620291A (zh)	2005-05-25
PE20030929A1 (es)	2003-11-05
UY27615A1 (es)	2003-08-29
HRP20040659A2 (en)	2004-10-31
WO2003061652A1 (en)	2003-07-31
KR20040077775A (ko)	2004-09-06
JP2005520811A (ja)	2005-07-14
TNSN04121A1 (en)	2006-06-01
NO20043457L (no)	2004-08-19
CA2472238A1 (en)	2003-07-31
EA200400716A1 (ru)	2004-12-30
ECSP045200A (es)	2004-08-27
WO2003061652A8 (en)	2004-09-10
MXPA04006573A (es)	2004-10-04
AR038197A1 (es)	2005-01-05
AP2004003084A0 (en)	2004-09-30
PA8563501A1 (es)	2004-08-31
PL371487A1 (en)	2005-06-13

Publication	Publication Date	Title
EP1736711A4 (en)	2011-12-21	HUMIDITY CONTROL
MA28630B1 (fr)	2007-06-01	Inhibiteurs d'iap
DE602004018007D1 (de)	2009-01-08	Stabilisiertes oled-bauelement
DE60321264D1 (de)	2008-07-10	Antriebsstranglagerung
NO20055742D0 (no)	2005-12-05	Gjenget forbindelse for stalror
ATE392813T1 (de)	2008-05-15	Fungizide wirkstoffkombination
EP2230467A4 (en)	2014-12-10	HUMIDITY CONTROL DEVICE
DK1358165T3 (da)	2009-05-11	Imidazolderivater
DK1311488T3 (da)	2010-01-04	Substituerede imidazoler som tafia-inhibitorer
ITMI20042462A1 (it)	2005-03-23	Memoria ausiliare
EP1511179A4 (en)	2006-10-04	ADAPTIVE CONTROLLER
IS7310A (is)	2004-06-14	3-(imídasólýl)-2-alkoxýprópanískar sýrur sem TAFIa hindrar
FI5430U1 (fi)	2002-07-17	Laatikko
DE502004011708D1 (de)	2010-11-11	Schirmartiger wäschetrockner
EP1739370A4 (en)	2009-07-29	HUMIDITY CONTROL
ATE427945T1 (de)	2009-04-15	Imidazolderivate
ITBO20040325A1 (it)	2004-08-20	Dispositivo per l'avvitamento di tappi su corrispondenti articoli
DE602004002369D1 (de)	2006-10-26	Sicherungsmutter
ATA13652003A (de)	2005-08-15	Schirmartiger wäschetrockner
ZA200405344B (en)	2005-07-01	3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors.
DE10393292D2 (de)	2005-06-16	Holzmantel
GB0202027D0 (en)	2002-03-13	3-(imidazolyl)-2-alkoxypropanoic acids
NO20033080D0 (no)	2003-07-04	Reguleringssele
DE60230770D1 (de)	2009-02-26	Verbesserte Speicheranordnung
GB0201911D0 (en)	2002-03-13	3-(Imidazolyl)-2-Aminopropanoic acids